Background and study aim : Vitamin D is a potent immunomodulator. It is reported to be related to the severity of fibrosis and responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C (CHC), so we aimed to evaluate if there is an association between vitamin D metabolism related genes and vitamin D level with the degree of liver damage and the response to treatment of CHC in our locality.
Patients and methods :
Two hundred and forty five Egyptian patients (123 patients with sustained virological response and 122 patients with treatment failure) were included. They were subjected to routine investigation needed for treatment, in addition to estimation of 25-OH vitamin D level in serum by ELISA and CYP27B1-1260 gene polymorphism by PCR-RFLP method.
Results:
We found that serum levels of vitamin D showed statistically significant increase in responders in comparison with non responders. The distribution of CYP27B1-1260 AC and CC genotypes were significantly presented in the non responders in comparison with the responders. CYP27B1-1260 AC and CC genotypes carriers had a high risk for treatment failure, (OR= 14.7, 95% CI= 2.3-20.1, P<0.001; OR = 20.4, 95% CI= 2.9-21.3, P<0.005 respectively). Serum levels of vitamin D showed statistically significant negative correlations with the activity and fibrosis of the liver in both responders and non responders. Also, there was negative correlation between vitamin D level and viral load in non responder patients (r= -.232, P=0.01). As regard the value of serum vitamin D level in discriminating responders from non responders; area under the ROC curve was 0.708 (95% CI 0.643-0.774). At a cutoff value of 19 ng/dL of serum vitamin D yielded sensitivity 79%, specificity 58%, positive predictive value (PPV) 65%, and negative predictive value (NPV) 73%.
INTRODUCTION
Egypt reports the highest prevalence of hepatitis C virus (HCV) world wide, ranging from 60% to more than 40% among regions and demographic group [1]. The recommended therapy for chronic hepatitis C, is pegylated interferon and ribavirin for 24 
PATIENTS AND METHODS
This cross-sectional study was carried out in Tropical Medicine Department and Medical Biochemistry Department, Zagazig University Hospital, 245 Egyptian patients with compensated liver function out of 270 patients with chronic HCV, their ages ranged from 18 to 65 years, were enrolled in this study during the period from January 2013 to January 2014. All patients were receiving Peg interferon-á-2b (1.5 ug/kg per week) plus ribavirin (1000-1200 mg/d). the studied population included 123 patients with sustained virological response defined as undetectable HCV RNA at 24 weeks post treatment and another 122 patients with treatment failure," a non-responder is someone who does not have disappearance of the HCV RNA, does not ever have a 2-log drop in hepatitis C viral load at 12 weeks, and if HCV RNA was still detectable at week 24 in those patients in whom HCV RNA dropped more than 2 log at 12 week [13]. Both groups were matched for age, sex and body mass index.
Exclusion criteria :
The patients were excluded from the study if their WBCs less than 4000/mm 3 , absolute neutrophil count of <1500 per mm 3 , a platelet count of <90 000 per mm 3 , hemoglobin level was abnormal, or if they had increased serum bilirubin more than 2 mg/dl [14] . Also patients with hepatitis B, auto immune hepatitis, metabolic liver disease, hepatocellular carcinoma, renal failure and heart failure, decompansated chronic liver disease, or those who had any problem necessities stoppage or interruption of treatment were excluded [15] . In addition to those who are previously treated or those were receiving adjuvant medication with immunemodulatory effect.
An informed consent was taken from each patient. All patients were subjected to complete history taking, full clinical examination, ultrasonographic and histopathological evaluation according to Metavair score [16].
Laboratory investigation :
All subjects were subjected to routine laboratory investigation including complete blood picture, liver function test and renal function test. Viral markers including hepatitis C virus antibodies (HCV Abs), hepatitis B surface antigen (HBsAg) and hepatitis B core antibodies (HBcAbs) were tested using ELISA. HCV RNA levels were determined by using the Real time PCR ( Step One Real-time PCR System, Applied Biosystem), performed strictly in accordance with the manufacturer's instructions. Serum alpha-feto protein, thyroid hormone (triiodothyronine (T3), thyroxine (T4) and thyroid stimulating hormone (TSH), anti nuclear antibodies (ANA Abs) and 25-OH vitamin D level in serum were measured using ELISA kits (kits provided by Biosource Europe S.A, Belguim).
Isolation of DNA :
Genomic DNA was extracted from EDTA whole blood using a spin column method according to the protocol (QI Aamp Blood Kit; Qiagen GmbH, Hilden, Germany).
Genetic polymorphism detection of the CYP27B1 gene :
The -1260C>A polymorphism (rs10877012) of the CYP27B1 gene was analyzed by restriction fragment length polymorphism-polymerase chain reaction (RFLP-PCR) method described by Jennings et al. [17] . The 1260 C was amplified in a single product using the primers forward 5-GTGTTCCCTAAGTGTTGTCTC-3 and reverse 5-GCTGACTCGGTCTCCTCTG-3. Fragments were amplified in 50μl reaction mixtures containing 10 μl genomic DNA, 30 µl one step PCR mixture (1 unit Taq polymerase, 10 mM KcL, 10 mM (NH 4 ) 2 SO 4 , 20mM Tris Hcl (PH 8.75), 0.1% Triton X-100, 0.1 mg/ml BSA and 200 µm dTNPs) and 2 μl of each primer (BioBasic Inc., Ontario, Canada) and 8 µl DdH 2 O. Reaction conditions used with the thermal cycler (Biometra, Göttingem, Germany) were as follows: an initial incubation at 94ºC for 5 minutes followed by 30 cycles of incubation at 94ºC for 45 seconds, 58ºC for 45 seconds and 72ºC for 45 seconds with a final extension at 72ºC for 7 minutes. Subsequently, it was subjected to digestion with TfiI enzyme, which cleaved the A allele into two fragments of 195 and 103 bp.
Statistical analysis :
Data were analyzed with SPSS for version 15.0 (statistical package for the Social Science, Chicago, IL). Quantitative data were expressed as mean  standard deviation (SD), data were analyzed by independent sample t and One Way Analysis Of Variance (ANOVA). While qualitative data were expressed as number and percentage and were analyzed by Chi square (X 2 ) test. Correlation was done using Pearson correlation test. The receiver operating characteristic (ROC) curve and 95% confidence interval (CI) was performed to determine cutoff values for serum level of Vitamin D. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were determined. Odds ratios (ORs) and confidence intervals (CI) were calculated. Pvalue was considered significant if <0.05 and highly significant if <0.001.
RESULTS
The study included 245 Egyptian patients (123 patients with sustained virological response and 122 patients with treatment failure), their clinical characteristics is shown in table (1). Serum levels of vitamin D showed statistically significant increase in responders in comparison with the non responders.
As regard distribution of of CYP27B1-1260 genotypes, AC and CC genotypes were significantly presented in the non responders in comparison with the responders. CYP27B1-1260 AC and CC genotypes carries had a high risk for treatment failure, (OR=14.7, 95% CI=2.3-20.1, P<0.001; OR= 20.4, 95% CI= 2.9-21.3, P<0.005 respectively).
Serum levels of vitamin D showed statistically significant decrease among those with advanced grading and staging, with a statistically significant negative correlation between vitamin D level and the activity and fibrosis of the liver in both responders and non responders.
Also, there was negative correlation between vitamin D level and viral load in non responder patients (r= -.232, P=0.01, data not shown). As regard the value of serum vitamin D level in discriminating responders from non responders; area under the ROC curve was 0.708 (95% CI 0.643-0.774), (Fig. 1) . At a cutoff value of 19 ng/dl of serum vitamin D yielded sensitivity 79%, specificity 58%, positive predictive value (PPV) 65%, and negative predictive value (NPV) 73%. Farghaly 
